Editor's note: The biological industry is a strategic emerging industry that is having a significant impact on human health, food, ecological environment, and sustainable development. A few days ago, GlobalIndustryAnalystsInc. (GIA) released a comprehensive report on the global biotechnology instrument market, showing that the global biotechnology instrument market is expected to reach 5.8 billion U.S. dollars in 2015.

        Seize the commanding heights of the global economy

        It seems that the bio-industry has become one of the fast-growing industries in the world. The global bio-industry sales almost double every 5 years, and the growth rate is 10 times the average growth rate of the world economy. Many developed countries and newly industrialized countries in the world have taken the bio-industry as a strategic choice to promote sustainable economic and social development and seize the commanding heights of the world economy and technology in the "post-financial crisis" era.

        The United States is currently the market with a large demand for global biotechnology instruments, followed by the European market. However, driven by the economic expansion of China and India, the Asia-Pacific region is a market with a fast-growing demand for biotechnology instruments. In addition, industries such as biotechnology, specialty chemicals, electronic products, and pharmaceuticals are gradually transforming into high-tech fields, and high-performance liquid chromatography equipment and supplies have become a segment of the market that is in great demand. In addition, researchers are now more and more inclined to the comprehensibility of the instrument and the rapidity of the system. Therefore, the programming of mass spectrometry and the automation of liquid chromatography (simplifying the operation process of chromatography) will be the market demand in the next few years. . Electrophoresis equipment and supplies have become a fast-growing segment of the market; DNA sequencing products rank second, and its demand is expected to increase by 3.5%.

        SMEs have a big impact

        According to reports, the development of the global biological industry is divided into three stages: the initial stage is 1980-2000, the growth stage is 2000-2010, and the mature stage will be after 2015. The world bio-industry is currently in the transitional period between the initial stage and the rapid growth stage, and a monopoly structure controlled by a few multinational companies has not yet formed. Compared with advanced countries in the world, the technology, talents and foundation of my country's bio-industry have small gaps in the high-tech fields, and rich in biological resources, which is an area that has the hope of achieving leapfrog development.

        As early as ten years ago, in drug research, the development of proteomics and the need for high-throughput technology, instruments and equipment have increasingly become an organic part of the laboratory, which has promoted the development of the bio-instrument industry, but with it The maturation of the market makes it more difficult for smaller companies to survive. Since there are leading companies in each market sector that occupy a larger market share in that sector, it is difficult for smaller companies to enter these areas. For these companies, the difficulty lies in the lack of the visibility that more powerful and well-known companies have.

        The sunrise industry has broad prospects

        But it is undeniable that compared with the international level, my country still has a gap in most areas of the biological industry. The chairman of the Chinese Society of Bioengineering and an academician of the Chinese Academy of Engineering pointed out that my country’s big gap in the field of biomedicine is that there are too few original drugs, 97% are generic drugs, and most of the products currently being made are expired products with very thin profits. In the future, the development of my country's bio-industry will focus on four major areas, namely biomedicine, bio-agriculture, medical equipment, and bio-industry, also known as bio-manufacturing.

        It is understood that the "Twelfth Five-Year" bio-industry plan led by the National Development and Reform Commission has begun to solicit public opinions. The National Development and Reform Commission and relevant departments have carried out relevant research work to promote the development of the biological industry from various aspects such as the technological innovation direction of the biological industry, the main tasks of industrialization and industrial development, industrial layout, market cultivation, talent training, as well as fiscal and taxation policies, investment and financing policies, etc. .

        This is undoubtedly a major benefit for companies in this field. Relevant persons pointed out that the inclusion of the bio-industry into a strategic emerging industry means that the bio-industry will usher in more national policies and financial support, and related listed companies will also benefit from it.

        It is estimated that by 2020, my country’s broad-based bio-industry market will reach 6 trillion yuan, including broad-based biomedicine market size of 4 trillion yuan, bio-manufacturing 1 trillion yuan, bio-agriculture 500 billion yuan, bio-energy 300 billion yuan, Bio-environmental protection is about 100 billion yuan. In the future, China's biotechnology companies will face greater opportunities and challenges.